1. Neopterin production in relation to COVID-19 in the Haut-Ogooué Province, Gabon
- Author
-
Serge Ely Dibakou, Chérone Nancy Mbani Mpega Ntigui, Sandrine Lydie Oyegue-Liabagui, Desire Otsague Ekore, Linaa Yasmine Okomo Nguema, Jean Bernard Lekana-Douki, and Barthelemy Ngoubangoye
- Subjects
SARS-CoV-2 ,COVID-19 ,Neopterin ,Biomarker ,Age ,Immunosenescence ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background In sub-Saharan Africa, understanding of the immune process associated with the COVID-19 pandemic remains scarce. This study aimed to investigate the relationship between plasma neopterin concentrations and COVID-19 infection, focusing on changes over time and age-related changes in immune response. Methods A retrospective case study was conducted during the first wave of COVID-19 from March to August 2020. Whole blood and associated symptoms and comorbidities were collected from patients of all ages and sexes. Concentrations of plasma neopterin were measured using a commercial competitive neopterin ELISA (Neopterin ELISA, IBL International GmbH, Germany). Results We analyzed data for 325 patients: 38% (n = 124) with COVID-19, and 62% (n = 201) without COVID-19, as a control group. We found that plasma neopterin concentrations were significantly higher in the COVID-19 group (mean value 45.1 nmol/L (SD 19)) than in the control group (mean value 33.8 nmol/L (SD 13)) (p = 0.004). In addition, neopterin levels decreased gradually over time in patients with COVID-19 (p
- Published
- 2024
- Full Text
- View/download PDF